Ronald S. Arellano
- Pulmonary and Respiratory Medicine top 1%
- Surgery top 2%
- Molecular Biology top 10%
- Radiology, Nuclear Medicine and Imaging top 1%
- Hepatology top 1%
- Co-authors
- Peter R. MüellerDebra A. GervaisFrancis J. McGovernW. Scott McDougalPeter F. HahnRaul N. UppotWenhui ZhouNisha I. Sainani
- Topics
- Renal cell carcinoma treatment (42 papers)Hepatocellular Carcinoma Treatment and Prognosis (30 papers)Renal and related cancers (25 papers)
- Partner nations
- United StatesChinaSpain
In The Last Decade
Ronald S. Arellano
145 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 109
- Pulmonary and Respiratory Medicine 2.2k
- Surgery 1.4k
- Molecular Biology 1000
- Radiology, Nuclear Medicine and Imaging 915
- Hepatology 740
Countries citing papers authored by Ronald S. Arellano
This map shows the geographic impact of Ronald S. Arellano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald S. Arellano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald S. Arellano more than expected).
Fields of papers citing papers by Ronald S. Arellano
This network shows the impact of papers produced by Ronald S. Arellano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald S. Arellano. The network helps show where Ronald S. Arellano may publish in the future.
Co-authorship network of co-authors of Ronald S. Arellano
This figure shows the co-authorship network connecting the top 25 collaborators of Ronald S. Arellano. A scholar is included among the top collaborators of Ronald S. Arellano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald S. Arellano. Ronald S. Arellano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 19 | |
| 4 | 7 | |
| 5 | 18 | |
| 6 | 6 | |
| 7 | 69 | |
| 8 | 28 | |
| 9 | 39 | |
| 10 | 115 | |
| 11 | 21 | |
| 12 | 143 | |
| 13 | 0 | |
| 14 | 55 | |
| 15 | 166 | |
| 16 | 12 | |
| 17 | 1 | |
| 18 | 35 | |
| 19 | 24 | |
| 20 | 22 |
About Ronald S. Arellano
Ronald S. Arellano is a scholar working on Hepatology, Pulmonary and Respiratory Medicine and Surgery, having authored 150 papers that have together received 4.0k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (42 papers), Hepatocellular Carcinoma Treatment and Prognosis (30 papers) and Renal and related cancers (25 papers). The work is most often cited by research in Hepatology (740 citations), Pulmonary and Respiratory Medicine (2.2k citations) and Radiology, Nuclear Medicine and Imaging (915 citations). Ronald S. Arellano has collaborated with scholars based in United States, China and Spain. Frequent co-authors include Peter R. Müeller, Debra A. Gervais, Francis J. McGovern, W. Scott McDougal, Peter F. Hahn, Raul N. Uppot, Debra A. Gervais, Wenhui Zhou, Nisha I. Sainani and Ashraf Thabet. Their work appears in journals such as Journal of Clinical Oncology, Gastroenterology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.